CAPCHEM(SZ:300037) Soochow Securities·2025-08-26 06:33Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company's performance in the first half of 2025 met market expectations, with revenue of 4.25 billion yuan, a year-on-year increase of 19%, and a net profit attributable to shareholders of 480 million yuan, up 16% year-on-year [8] - The electrolyte segment is expected to maintain a growth rate of 30% in 2025, with shipments projected to reach 280,000 to 300,000 tons, and overseas customers expected to account for 15-20% of total shipments [8] - The fluorochemical segment showed a profit increase of over 10% quarter-on-quarter, with a projected annual profit contribution of over 800 million yuan [8] - The company has improved its cost control capabilities, with a stable expense ratio and significant improvement in operating cash flow [8] - The target price for the stock is set at 65.4 yuan, based on a 30x PE ratio for 2026 [8] Financial Summary - Total revenue is projected to grow from 7.84 billion yuan in 2024 to 17.78 billion yuan in 2027, with a compound annual growth rate (CAGR) of 27.64% [9] - Net profit attributable to shareholders is expected to increase from 942 million yuan in 2024 to 2.03 billion yuan in 2027, reflecting a CAGR of 24.10% [9] - The latest diluted EPS is forecasted to rise from 1.26 yuan in 2024 to 2.71 yuan in 2027 [9] - The company's P/E ratio is projected to decrease from 37.61 in 2024 to 17.49 in 2027, indicating an improving valuation [9]